Charles River Labs Intl buy Barclays PLC
Start price
06.11.25
/
50%
€149.35
Target price
06.11.26
€182.47
Performance (%)
67.19%
Price
20.08.26
€249.70
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Charles River Labs Intl has seen massive gains of 67.19%. This prediction currently runs until 06.11.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Charles River Labs Intl | 2.378% | 2.378% |
| iShares Core DAX® | -1,06 % | 5,01 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % |
| iShares S&P 500 | -1,78 % | 1,39 % |
Comments by Barclays_PLC for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International (NYSE:CRL) had its price target raised by analysts at Barclays PLC from $195.00 to $210.00. They now have an "overweight" rating on the stock.
Ratings data for CRL provided by MarketBeat
Stopped prediction by Barclays_PLC for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€225.40
05.08.26
05.08.26
-
05.08.27
05.08.27
9.94%
20.08.26
20.08.26
Charles River Labs Intl
Start price
Target price
Perf. (%)
€151.30
08.05.26
08.05.26
-
08.05.27
08.05.27
59.42%
20.08.26
20.08.26
Charles River Labs Intl
Start price
Target price
Perf. (%)
€149.30
02.10.25
02.10.25
€166.12
02.10.26
02.10.26
67.25%
20.08.26
20.08.26